Intravenous (IV) Solutions Market Analysis by Type And Segment Forecasts to 2024

  • ID: 3934162
  • Report
  • 65 pages
  • Grand View Research
1 of 3
The global IV solutions market was valued at USD 6.9 billion in 2015 and is expected to reach a value of USD 13.79 billion by 2024. Key factors driving market expansion include the rapidly increasing natality rate including a high percentage of premature births and malnutrition.

Growing incidence rate of chronic diseases, such as cancer, is also fueling the demand for Total Parenteral Nutrition (TPN), which forms a vital part of the treatment. Intravenous nutrition helps sustain strength, maintains hydration levels in patients, and facilitates faster recovery. Cancer prevalence is forecasted to grow by 70% over the next few decades. This poses a colossal growth prospect for the market.

The regulatory bodies are approving high-quality products complying with faster patient recovery. In May 2016, Amanta Healthcare received approval for NaCl injection BP and Sterile water injection BP products. These products obtained Therapeutic Goods Administration approval granted by the Australian government.

The reimbursement scenario for IV nutrition is promising. In the U.S., Medicare covers up to 80% of the expenses of parenteral and enteral nutrition including physician services, medical equipment, and other related medical services. In the developing countries, increasing purchasing power compensates for the absence of reimbursement coverage thus sustaining the growth of this vertical.

Further Key Findings From the Study Suggest:

TPN dominated the market in 2015. TPN is administered to patients who are ‘nil by mouth’ or are afflicted with dysfunctional digestive systems. Around 2000 elderly deaths occur per annum due to malnutrition. With rising geriatric population and chronic, but manageable diseases, the demand for TPN is projected to grow over the forecast period.

In 2015, North America dominated the market with a revenue share of around 40%. The region has a large geriatric population base comprising 45% long-term care residents and 40% hospitalized, elderly patients suffering from malnutrition. Moreover, in 2014, the region experienced a sharp shortage of IV fluids due to increased hospitalization of influenza patients. In response to the deficit, FDA initiatives were directed toward expediting the application review process and identifying potential new manufacturers.

Asia Pacific is expected to emerge as the fastest growing region. The rising geriatric population in Japan and China, increasing tendencies of unhealthy food consumption, and low level of awareness is expected to promote the emergence of IV solutions market in this region.

Fresenius Kabi AG, Baxter, B. Braun Melsungen AG, and Hospira are few players operating in the market. Mergers and acquisitions are certain strategic initiatives undertaken by the companies. For instance, Claris-Otsuka is a joint venture between Claris Lifesciences Ltd., Otsuka Pharmaceutical Co., Ltd., and Mitsui & Co., Ltd., Japan established in 2012. This joint venture focused on the manufacturing and marketing activities for IV nutrition products and offers products in various IV delivery systems.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1 Research Methodology
1.1 Information Procurement
2 Executive Summary
3 IV Solutions Industry Outlook
3.1 Market Segmentation
3.2 Market Size and Growth Prospects, 2013 - 2024
3.3 IV Solutions Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Increasing natality rate
3.3.1.2 Rising number of premature births
3.3.1.3 Risk of malnutrition
3.3.1.4 Rising geriatric population base
3.3.1.5 Increasing incidence of cancer
3.3.2 Market restraint analysis
3.3.2.1 Shortage of parenteral nutrition products
3.3.2.2 Increased use of enteral nutrition
3.3.2.3 High risk of infection
3.3.2.4 Stringent regulations
3.4 Key Opportunities Prioritized
3.5 Clinical nutrition market: 2014 (E) percentage market share of major companies
3.6 Intravenous solution products market: 2013 percentage market share of major companies
3.7 Competition analysis (Strategic Initiatives)
3.8 Industry Analysis - Porter’s
3.9 IV Solutions PESTEL Analysis
3.10 Product technology/Research
4 Market Categorization 1: Type Estimates & Trend Analysis
4.1 Global IV Solutions Market: Type Movement Analysis
4.2 Total Parenteral Nutrition Market (TPN)
4.2.1 Total Parenteral Nutrition Market (TPN) market estimates and forecasts, 2013 - 2024 (USD Million)
4.3 Peripheral Parenteral Nutrition (PPN)
4.3.1 Peripheral Parenteral Nutrition (PPN) market estimates and forecasts, 2013 - 2024 (USD Million)
5 Market Categorization 2: Nutrient Estimates & Trend Analysis
5.1 Nutrient Movement Analysis & Market Share, 2015 & 2024
5.2 Carbohydrates
5.2.1 Carbohydrates market estimates and forecasts, 2013 - 2024 (USD Million)
5.3 Single dose amino acid solution
5.3.1 Single dose amino acid solution market estimates and forecasts, 2013 - 2024 (USD Million)
5.4 Vitamins & minerals (salt and electrolyte)
5.4.1 Vitamins & minerals (salt and electrolyte) market estimates and forecasts, 2013 - 2024 (USD Million)
5.5 Parenteral lipid emulsion
5.5.1 Parenteral lipid emulsion market estimates and forecasts, 2013 - 2024 (USD Million)
5.6 Others (trace elements)
5.6.1 Others (trace elements) market estimates and forecasts, 2013 - 2024 (USD Million)
6 Market Categorization 3: Regional Estimates & Trend Analysis, by Type & Nutrient
6.1 Regional Movement Analysis & Market Share, 2015 & 2024
6.2 North America
6.2.1 North America IV solutions market, by type, 2013 - 2024 (USD Million)
6.2.2 North America IV solutions market, by nutrient, 2013 - 2024 (USD Million)
6.2.3 U.S.
6.2.3.1 U.S. IV solutions market, by type, 2013 - 2024 (USD Million)
6.2.3.2 U.S. IV solutions market, by nutrient, 2013 - 2024 (USD Million)
6.2.4 Canada
6.2.4.1 Canada IV solutions market, by type, 2013 - 2024 (USD Million)
6.2.4.2 Canada IV solutions market, by nutrient, 2013 - 2024 (USD Million)
6.3 Europe
6.3.1 Europe IV solutions market, by type, 2013 - 2024 (USD Million)
6.3.2 Europe IV solutions market, by nutrient, 2013 - 2024 (USD Million
6.3.3 Germany
6.3.3.1 Germany IV solutions market, by type, 2013 - 2024 (USD Million)
6.3.3.2 Germany IV solutions market, by nutrient, 2013 - 2024 (USD Million)
6.3.4 UK
6.3.4.1 UK IV solutions market, by type, 2013 - 2024 (USD Million)
6.3.4.2 UK IV solutions market, by nutrient, 2013 - 2024 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific IV Solutions market, by type, 2013 - 2024 (USD Million)
6.4.2 Asia Pacific IV Solutions market, by nutrient, 2013 - 2024 (USD Million)
6.4.3 Japan
6.4.3.1 Japan IV Solutions market, by type, 2013 - 2024 (USD Million)
6.4.3.2 Japan IV Solutions market, by nutrient, 2013 - 2024 (USD Million)
6.4.4 China
6.4.4.1 China IV Solutions market, by type, 2013 - 2024 (USD Million)
6.4.4.2 China IV Solutions market, by nutrient, 2013 - 2024 (USD Million)
6.4.5 India
6.4.5.1 India IV Solutions market, by type, 2013 - 2024 (USD Million)
6.4.5.2 India IV Solutions market, by nutrient, 2013 - 2024 (USD Million)
6.4.6 Australia
6.4.6.1 Australia IV Solutions market, by type, 2013 - 2024 (USD Million)
6.4.6.2 Australia IV Solutions market, by nutrient, 2013 - 2024 (USD Million)
6.5 Latin America
6.5.1 Latin America IV Solutions market, by type, 2013 - 2024 (USD Million)
6.5.2 Latin America IV Solutions market, by nutrient, 2013 - 2024 (USD Million)
6.5.3 Brazil
6.5.3.1 Brazil IV Solutions market, by type, 2013 - 2024 (USD Million)
6.5.3.2 Brazil IV Solutions market, by nutrient, 2013 - 2024 (USD Million)
6.5.4 Mexico
6.5.4.1 Mexico IV Solutions market, by type, 2013 - 2024 (USD Million)
6.5.4.2 Mexico IV Solutions market, by nutrient, 2013 - 2024 (USD Million)
6.6 MEA
6.6.1 MEA IV Solutions market, by type, 2013 - 2024 (USD Million)
6.6.2 MEA IV Solutions market, by nutrient, 2013 - 2024 (USD Million)
6.6.3 South Africa
6.6.3.1 South Africa IV Solutions market, by type, 2013 - 2024 (USD Million)
6.6.3.2 South Africa IV Solutions market, by nutrient, 2013 - 2024 (USD Million)
7 Competitive Landscape
7.1 Fresenius Kabi
7.1.1 Company overview
7.1.2 Financial performance
7.1.3 Product benchmarking
7.1.4 Strategic initiatives
7.2 Sino-Swed Pharmaceutical Corp., Ltd.
7.2.1 Company overview
7.2.2 Financial performance
7.2.3 Product benchmarking
7.2.4 Strategic initiatives
7.3 Hospira
7.3.1 Company overview
7.3.2 Financial performance
7.3.3 Product benchmarking
7.3.4 Strategic initiatives
7.4 Amanta Healthcare
7.4.1 Company overview
7.4.2 Financial performance
7.4.3 Product benchmarking
7.4.4 Strategic initiatives
7.5 Otsuka Pharmaceutical Co., Ltd.
7.5.1 Company overview
7.5.2 Financial performance
7.5.3 Product benchmarking
7.5.4 Strategic initiatives
7.6 Sichuan Kelun Pharmaceutical Co., Ltd.
7.6.1 Company overview
7.6.2 Financial performance
7.6.3 Product benchmarking
7.6.4 Strategic Initiatives
7.7 Terumo Corporation
7.7.1 Company overview
7.7.2 Financial performance
7.7.3 Product benchmarking
7.7.4 Strategic initiatives
7.8 Baxter
7.8.1 Company overview
7.8.2 Financial performance
7.8.3 Product benchmarking
7.8.4 Strategic initiatives
7.9 B. Braun Melsungen AG
7.9.1 Company overview
7.9.2 Financial performance
7.9.3 Product benchmarking
7.9.4 Strategic initiatives
7.10 Claris Lifesciences Ltd.
7.10.1 Company overview
7.10.2 Financial performance
7.10.3 Product benchmarking
7.10.4 Strategic initiatives
7.11 Kyowa Hakko Bio Co., Ltd.
7.11.1 Company overview
7.11.2 Financial performance
7.11.3 Product benchmarking
7.11.4 Strategic initiatives
7.12 Grifols
7.12.1 Company overview
7.12.2 Financial performance
7.12.3 Product benchmarking
7.12.4 Strategic initiatives
7.13 Liqvor Pharmaceuticals
7.13.1 Company overview
7.13.2 Financial performance
7.13.3 Product benchmarking
7.13.4 Strategic initiatives

List of Tables

Table 1 Intravenous solutions - global market current and forecast by regions (2015 - 2024) in (USD Million)
Table 2 North America IV solutions market estimates and forecasts, by region, 2013 - 2024 (USD Million)
Table 3 North America IV solutions market estimates and forecasts, by type, 2013 - 2024 (USD Million)
Table 4 North America IV solutions market estimates and forecasts, by nutrient, 2013 - 2024 (USD Million)
Table 5 U.S. IV solutions market estimates and forecasts, by type, 2013 - 2024 (USD Million)
Table 6 U.S. IV solutions market estimates and forecasts, by nutrient, 2013 - 2024 (USD Million)
Table 7 Canada IV solutions market estimates and forecasts, by type, 2013 - 2024 (USD Million)
Table 8 Canada IV solutions market estimates and forecasts, by nutrient, 2013 - 2024 (USD Million)
Table 9 Europe IV solutions market estimates and forecasts, by region, 2013 - 2024 (USD Million)
Table 10 Europe IV solutions market estimates and forecasts, by type, 2013 - 2024 (USD Million)
Table 11 Europe IV solutions market estimates and forecasts, by nutrient, 2013 - 2024 (USD Million)
Table 12 UK IV solutions market estimates and forecasts, by type, 2013 - 2024 (USD Million)
Table 13 UK IV solutions market estimates and forecasts, by nutrient, 2013 - 2024 (USD Million)
Table 14 Germany IV solutions market estimates and forecasts, by type, 2013 - 2024 (USD Million)
Table 15 Germany IV solutions market estimates and forecasts, by nutrient, 2013 - 2024 (USD Million)
Table 16 Asia Pacific IV solutions market estimates and forecasts, by region, 2013 - 2024 (USD Million)
Table 17 Asia Pacific IV solutions market estimates and forecasts, by type, 2013 - 2024 (USD Million)
Table 18 Asia Pacific IV solutions market estimates and forecasts, by nutrient, 2013 - 2024 (USD Million)
Table 19 Japan IV solutions market estimates and forecasts, by type, 2013 - 2024 (USD Million)
Table 20 Japan IV solutions market estimates and forecasts, by nutrient, 2013 - 2024 (USD Million)
Table 21 China IV solutions market estimates and forecasts, by type, 2013 - 2024 (USD Million)
Table 22 China IV solutions market estimates and forecasts, by nutrient, 2013 - 2024 (USD Million)
Table 23 India IV solutions market estimates and forecasts, by type, 2013 - 2024 (USD Million)
Table 24 India IV solutions market estimates and forecasts, by nutrient, 2013 - 2024 (USD Million)
Table 25 Australia IV solutions market estimates and forecasts, by type, 2013 - 2024 (USD Million)
Table 26 Australia IV solutions market estimates and forecasts, by nutrient, 2013 - 2024 (USD Million)
Table 27 Latin America IV solutions market estimates and forecasts, by region, 2013 - 2024 (USD Million)
Table 28 Latin America IV solutions market estimates and forecasts, by type, 2013 - 2024 (USD Million)
Table 29 Latin America IV solutions market estimates and forecasts, by nutrient, 2013 - 2024 (USD Million)
Table 30 Brazil IV solutions market estimates and forecasts, by type, 2013 - 2024 (USD Million)
Table 31 Brazil IV solutions market estimates and forecasts, by nutrient, 2013 - 2024 (USD Million)
Table 32 Mexico IV solutions market estimates and forecasts, by type, 2013 - 2024 (USD Million)
Table 33 Mexico IV solutions market estimates and forecasts, by nutrient, 2013 - 2024 (USD Million)
Table 34 MEA IV solutions market estimates and forecasts, by region, 2013 - 2024 (USD Million)
Table 35 MEA IV solutions market estimates and forecasts, by type, 2013 - 2024 (USD Million)
Table 36 MEA IV solutions market estimates and forecasts, by nutrient, 2013 - 2024 (USD Million)
Table 37 South Africa IV solutions market estimates and forecasts, by type, 2013 - 2024 (USD Million)
Table 38 South Africa IV solutions market estimates and forecasts, by nutrient, 2013 - 2024 (USD Million)

List of Figures

Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 IV solutions Market Segmentation
Figure 5 Market Size and Growth Prospects, 2013 - 2024
Figure 6 IV Solutions Market Dynamics
Figure 7 North America geriatric population (Over 60 Years) (Million) (2014 - 2022)
Figure 8 Cancer (all types) incidences per 100,000 populations, 2012
Figure 9 Key Opportunity Prioritized
Figure 10 IV Solutions market - Porter’s analysis
Figure 11 IV Solutions market - PESTLE analysis
Figure 12 IV solutions Market Type Outlook Key Takeaways
Figure 13 IV solutions Market Nutrients Outlook Key Takeaways
Figure 14 IV solutions Market: Type Movement Analysis
Figure 15 Global IV solutions market, by type 2013 - 2024 (USD Million)
Figure 16 Global Total Parenteral Nutrition Market (TPN) market, 2013 - 2024 (USD Million)
Figure 17 Global Peripheral Parenteral Nutrition (PPN) market, 2013 - 2024 (USD Million)
Figure 18 IV solutions Market: Nutrient Movement Analysis
Figure 19 Global carbohydrates market, 2013 - 2024 (USD Million)
Figure 20 Global single dose amino acid solution market, 2013 - 2024 (USD Million)
Figure 21 Global vitamins & minerals (salt and electrolyte) market, 2013 - 2024 (USD Million)
Figure 22 Global parenteral lipid emulsion market, 2013 - 2024 (USD Million)
Figure 23 Global others (trace elements) market, 2013 - 2024 (USD Million)
Figure 24 Regional market place: Key takeaways
Figure 25 IV solutions Regional outlook, 2015 & 2024
Figure 26 North America IV solutions market, 2013 - 2024 (USD Million)
Figure 27 U.S. IV solutions market, 2013 - 2024 (USD Million)
Figure 28 Canada IV solutions market, 2013 - 2024 (USD Million)
Figure 29 Europe IV solutions market, 2013 - 2024 (USD Million)
Figure 30 Germany IV solutions market, 2013 - 2024 (USD Million)
Figure 31 UK IV solutions market, 2013 - 2024 (USD Million)
Figure 32 Asia Pacific IV solutions market, 2013 - 2024 (USD Million)
Figure 33 Japan IV solutions market, 2013 - 2024 (USD Million)
Figure 34 China IV solutions market, 2013 - 2024 (USD Million)
Figure 35 India IV solutions market, 2013 - 2024 (USD Million)
Figure 36 Australia IV solutions market, 2013 - 2024 (USD Million)
Figure 37 Latin America IV solutions market, 2013 - 2024 (USD Million)
Figure 38 Brazil IV solutions market, 2013 - 2024 (USD Million)
Figure 39 Mexico IV solutions market, 2013 - 2024 (USD Million
Figure 40 Middle East IV solutions market, 2013 - 2024 (USD Million)
Figure 41 South Africa IV solutions market, 2013 - 2024 (USD Million)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll